Diabetic neuropathic pain field presents significant opportunity for drug developers, says GlobalData
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
EZHARMIA is the fifth innovative oncology medicine to be launched in Japan by Daiichi Sankyo in the past three years
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
The Halol facility was placed under Import Alert by USFDA.
Sanjeev is currently the Country President for AstraZeneca Malaysia
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Subscribe To Our Newsletter & Stay Updated